Q3 Results Update: BSE, Pfizer, Bata India, and Graphite India Surge
- Share.Market
- 3 min read
- Published at : 10 Feb 2026 03:17 PM
- Modified at : 10 Feb 2026 03:17 PM
Over 160 companies, including BSE, Pfizer, Bata India, and Graphite India, posted their results for the October to December quarter of the financial year 2025-26.
Here are their consolidated financial results, compared on a year-on-year basis (with the corresponding quarter of the previous year).
BSE Ltd
BSEAsia’s oldest stock exchange reported a consolidated net profit of ₹603 crore, up 167% from ₹226 crore reported in the corresponding quarter of the previous year. Its revenue increased 62% to ₹1,244 crore during the quarter, compared to ₹768 crore in the previous year.
Pfizer
PFIZERThe biopharmaceutical company’s net profit rose 11% year-on-year to ₹142 crore compared with ₹128 crore in the same period last year. Its revenue from operations increased by 20% YoY to ₹645 crore, up from ₹538 crore in the corresponding period of the previous year.
Bata India
BATAINDIAThe shoemaker’s revenue rose nearly 3% year-on-year to ₹945 crore, compared with ₹919 crore in the same period a year ago. Its profit after tax climbed nearly 13% year-on-year to ₹66 crore from ₹59 crore in the corresponding quarter a year ago.
Graphite India
GRAPHITEIndia’s largest producer of graphite electrodes reported a 23% increase in revenue from operations to ₹642 crore compared to ₹523 crore in the same period last year. It reported a net profit of ₹67 crore, compared to a loss of ₹21 crore in the corresponding quarter a year earlier.
